相关实验视频

Updated: Jan 10, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

埃博拉病毒在西非爆发期间的人类适应

Richard A Urbanowicz¹, C Patrick McClure¹, Anavaj Sakuntabhai²

¹School of Life Sciences, The University of Nottingham, Nottingham NG7 2RD, UK; NIHR Nottingham Digestive Diseases Biomedical Research Unit, The University of Nottingham, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.

|November 5, 2016

概括

西非疫情期间埃博拉病毒 (EBOV) 的基因组变化增强了它感染人类细胞的能力. 这些突变可能有助于增加人与人之间的传染性和病毒的传播.

科学领域:

病毒学
基因组学
流行病学

背景情况:

2013-2016年西非埃博拉病毒 (EBOV) 爆发是最大的记录,起源于跨物种传播.
遗传学分析表明在疫情期间存在多种EBOV血统的共同流通.

研究的目的:

调查EBOV在人体中长期流通是否导致基因组变化,从而提高人类的传染性.
确定EBOV糖蛋白 (GP) 中特定氨基酸替代对病毒热带的影响.

主要方法:

基于早期分离的合成EBOVGP结构的生成.
在GP中引入定义血统的氨基酸替代.
在人类和蝙蝠细胞系中进行感染测试的伪病毒与突变GP的创建.

主要成果:

在EBOVGP中,特定的氨基酸替代物显著增加了人体细胞的热带性.
这些替代同时减少了蝙蝠细胞的病毒热带性.
观察到的变化表明人类群体的感染性和传染性增强.

结论:

西非疫情期间EBOV GP的基因组适应有利于人类细胞感染.
这些适应可能在某些 EBOV 血统的人际传播和地理传播的增加中发挥了作用.

关键词:

埃博拉病毒马科纳适应情况一个蝙蝠这种病一个进化人类伪病毒热带主义

更多相关视频

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

相关概念视频

Cross-reactivity

Cross-reactivity

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...